Mallory Powell

UK is First in U.S. to Conduct Trial of Promising New Treatment Strategy for Parkinson's Disease

Published: Nov 18, 2013

LEXINGTON, Ky. (Nov. 18, 2013) -- University of Kentucky physicians will discuss today at 10 a.m., 317 Charles T Wethington Jr. Building, the clinical trial of a new treatment strategy for Parkinson’s disease that, if successful, could drastically change future treatment of the disease and possibly halt or reverse brain degeneration.  UK is the first in the U.S. to conduct the clinical trial. A patient with Parkinson’s disease will also be present to tell his story.     

###

 

Media Contact: Mallory Powell, mallory.powell @uky.edu  

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

WHO:  UK President Dr. Eli Capilouto; Dr. Craig van Horne, UK associate professor of neurosurgery and principle investigator of the clinical trial; Dr. Greg A. Gerhardt, UK professor of anatomy & neurobiology and director of the Morris K. Udall Parkinson's Disease Research Center of Excellence; and Rodney Parsons, UK HealthCare patient from Lexington with Parkinson’s disease.

 

WHEN:  10 a.m., Monday, Nov. 18, 2013

 

WHERE:  317 Conference Room in the Charles T. Wethington Jr. Building

 

PARKING INFORMATION: Parking is available in the Kentucky Clinic Parking Garage located on Huguelet Drive. The Wethington Building can be accessed by walking through the Kentucky Clinic. For more information or directions, call (859) 806-0445 or (615) 828-0000.

 

MORE: Parkinson’s disease is one of the most common neurological disorders, affecting one million Americans. There is currently no cure, but symptoms can be managed through medication and a surgical procedure called deep brain stimulation (DBS). The University of Kentucky is conducting a first-of-its-kind clinical trial to explore a novel, regenerative treatment strategy for Parkinson’s that combines the DBS procedure with grafting of a patient’s own nerve tissue into the brain, anticipating that the nerve graft will allow the brain to heal itself.

 

If successful, this procedure could drastically change the treatment of Parkinson’s disease and could possibly halt or reverse the brain degeneration caused by the disease. To date, five patients have undergone the combined procedure as part of the trial and preliminary data indicates that the procedure is safe and more effective than DBS alone. 

parkinsons.jpg
August
 
 
 
 
 
 
1
 
Sat
2
 
Sun
3
 
Mon
4
 
Tue
5
 
Wed
6
 
Thu
7
Curator Tour
Fri
8
 
Sat
9
 
Sun
10
 
Mon
11
 
Tue
12
 
Wed
13
 
Thu
14
 
Fri
15
 
Sat
16
 
Sun
17
 
Mon
18
We Are UK
Tue
19
 
Wed
20
 
Thu
21
Parent and Families Reception
Fri
22
K Team Meeting: K Week Overview
Big Blue U
Campus Ruckus
Sat
23
Bowman's Bash
K Team Meeting: Lunch and Campus Tour
UK Lex-Mart
Sun
24
K Team Meeting: Dinner with Your K Team
Mon
25
K Team Meeting: Common Reading Experience Discussion
Tue
26
 
Wed
27
 
Thu
28
 
Fri
29
 
Sat
30
 
Sun
31
 
Mon
 
 
 
 
 
Aug 07
Curator Tour 08/07/2015

Fri, 08/07/2015

Tue, 08/18/2015

Fri, 08/21/2015

Sat, 08/22/2015

Reset Page